Have a personal or library account? Click to login
A Survey on Publicly Available Open Datasets Derived From Electronic Health Records (EHRs) of Patients with Neuroblastoma Cover

A Survey on Publicly Available Open Datasets Derived From Electronic Health Records (EHRs) of Patients with Neuroblastoma

Data Science Journal
Volume 21 (2022): Issue 1
By: Davide Chicco,  Gabriel Cerono and  Davide Cangelosi  
Open Access
|Oct 2022

References

  1. 1Abe, M, Ohira, M, Kaneda, A, Yagi, Y, Yamamoto, S, Kitano, Y, Takato, T, Nakagawara, A and Ushijima, T. 2005. CpG island methylator phenotype is a strong determinant of poor prognosis in neuroblastomas. Cancer Research, 65(3): 828–834. DOI: 10.1158/0008-5472.828.65.3
    Back to article
  2. 2Adkins, DE. 2017. Machine learning and electronic health records: A paradigm shift. American Journal of Psychiatry, 174(2): 93–94. DOI: 10.1176/appi.ajp.2016.16101169
    Back to article
  3. 3American Cancer Society. 2021. Key statistics about neuroblastoma. https://www.cancer.org/cancer/neuroblastoma/about/key-statistics.html URL visited on 11th November 2021.
    Back to article
  4. 4Attiyeh, EF, London, WB, Mossé, YP, Wang, Q, Winter, C, Khazi, D, McGrady, PW, Seeger, RC, Look, AT, Shimada, H, Brodeur, GM, Cohn, SL, Matthay, KK and Maris, JM. 2005. Chromosome 1p and 11q deletions and outcome in neuroblastoma. New England Journal of Medicine, 353(21): 2243–2253. DOI: 10.1056/NEJMoa052399
    Back to article
  5. 5Banelli, B, Bonassi, S, Casciano, I, Mazzocco, K, Di Vinci, A, Scaruffi, P, Brigati, C, Allemanni, G, Borzì, L, Tonini, GP and Romani, M. 2010. Outcome prediction and risk assessment by quantitative pyrosequencing methylation analysis of the SFN gene in advanced stage, high-risk, neuroblastic tumor patients. International Journal of Cancer, 126(3): 656–668. DOI: 10.1002/ijc.24768
    Back to article
  6. 6Banelli, B, Di Vinci, A, Gelvi, I, Casciano, I, Allemanni, G, Bonassi, S and Romani, M. 2005a. DNA methylation in neuroblastic tumors. Cancer Letters, 228(1–2): 37–41. DOI: 10.1016/j.canlet.2005.02.049
    Back to article
  7. 7Banelli, B, Gelvi, I, Di Vinci, A, Scaruffi, P, Casciano, I, Allemanni, G, Bonassi, S, Tonini, GP and Romani, M. 2005b. Distinct CpG methylation profiles characterize different clinical groups of neuroblastic tumors. Oncogene, 24(36): 5619–5628. DOI: 10.1038/sj.onc.1208722
    Back to article
  8. 8Banelli, B, Merlo, DF, Allemanni, G, Forlani, A and Romani, M. 2013. Clinical potentials of methylator phenotype in stage 4 high-risk neuroblastoma: an open challenge. PLOS One, 8(5): e63253. DOI: 10.1371/journal.pone.0063253
    Back to article
  9. 9Barco, S, Gennai, I, Reggiardo, G, Galleni, B, Barbagallo, L, Maffia, A, Viscardi, E, De Leonardis, F, Cecinati, V, Sorrentino, S, Garaventa, A, Conte, M and Cangemi, G. 2014. Urinary homovanillic and vanillylmandelic acid in the diagnosis of neuroblastoma: Report from the Italian Cooperative Group for Neuroblastoma. Clinical Biochemistry, 47(9): 848–852. DOI: 10.1016/j.clinbiochem.2014.04.015
    Back to article
  10. 10Basta, NO, Halliday, GC, Makin, G, Birch, J, Feltbower, R, Bown, N, Elliott, M, Moreno, L, Barone, G, Pearson, AD, James, PW, Tweddle, DA and McNally, RJ. 2016. Factors associated with recurrence and survival length following relapse in patients with neuroblastoma. British Journal of Cancer, 115(9): 1048–1057. DOI: 10.1038/bjc.2016.302
    Back to article
  11. 11Bernstein, ML, Leclerc, JM, Bunin, G, Brisson, L, Robison, L, Shuster, J, Byrne, T, Gregory, D, Hill, G and Dougherty, G. 1992. A population-based study of neuroblastoma incidence, survival, and mortality in North America. Journal of Clinical Oncology, 10(2): 323–329. DOI: 10.1200/JCO.1992.10.2.323
    Back to article
  12. 12Bertagnolli, MM, Sartor, O, Chabner, BA, Rothenberg, ML, Khozin, S, Hugh-Jones, C, Reese, DM and Murphy, MJ. 2017. Advantages of a truly open-access data-sharing model. New England Journal of Medicine, 376(12): 1178–1181. DOI: 10.1056/NEJMsb1702054
    Back to article
  13. 13Bown, N, Cotterill, S, Łastowska, M, O’Neill, S, Pearson, AD, Plantaz, D, Meddeb, M, Danglot, G, Brinkschmidt, C, Christiansen, H, Laureys, G, Nicholson, J, Bernheim, A, Betts, DR, Vandesompele, J, Van Roy, N and Speleman, F. 1999. Gain of chromosome arm 17q and adverse outcome in patients with neuroblastoma. New England Journal of Medicine, 340(25): 1954–1961. DOI: 10.1056/NEJM199906243402504
    Back to article
  14. 14Brodeur, GM and Bagatell, R. 2014. Mechanisms of neuroblastoma regression. Nature Reviews Clinical Oncology, 11(12): 704–713. DOI: 10.1038/nrclinonc.2014.168
    Back to article
  15. 15CAMDA. 2017. Neuroblastoma data integration challenge. http://camda2017.bioinf.jku.at/doku.php/contest_dataset#neuroblastoma_data_integration_challenge URL visited on 18th January 2022.
    Back to article
  16. 16Cangelosi, D, Blengio, F, Versteeg, R, Eggert, A, Garaventa, A, Gambini, C, Conte, M, Eva, A, Muselli, M and Varesio, L. 2013. Logic learning machine creates explicit and stable rules stratifying neuroblastoma patients. BMC Bioinformatics, 14(7): 1–20. DOI: 10.1186/1471-2105-14-S7-S12
    Back to article
  17. 17Cangelosi, D, Morini, M, Zanardi, N, Sementa, AR, Muselli, M, Conte, M, Garaventa, A, Pfeffer, U, Bosco, MC, Varesio, L and Eva, A. 2020. Hypoxia predicts poor prognosis in neuroblastoma patients and associates with biological mechanisms involved in telomerase activation and tumor microenvironment reprogramming. Cancers, 12(9): 2343. DOI: 10.3390/cancers12092343
    Back to article
  18. 18Cangelosi, D, Muselli, M, Parodi, S, Blengio, F, Becherini, P, Versteeg, R, Conte, M and Varesio, L. 2014. Use of attribute driven incremental discretization and logic learning machine to build a prognostic classifier for neuroblastoma patients. BMC Bioinformatics, 15(5): 1–15. DOI: 10.1186/1471-2105-15-S5-S4
    Back to article
  19. 19Cangelosi, D, Pelassa, S, Morini, M, Conte, M, Bosco, MC, Eva, A, Sementa, AR and Varesio, L. 2016. Artificial neural network classifier predicts neuroblastoma patients’ outcome. BMC Bioinformatics, 17(12): 83–93. DOI: 10.1186/s12859-016-1194-3
    Back to article
  20. 20Cangemi, G, Reggiardo, G, Barco, S, Barbagallo, L, Conte, M, D’Angelo, P, Bianchi, M, Favre, C, Galleni, B, Melioli, G, Haupt, R, Garaventa, A and Corrias, MV. 2012. Prognostic value of ferritin, neuron-specific enolase, lactate dehydrogenase, and urinary and plasmatic catecholamine metabolites in children with neuroblastoma. OncoTargets and Therapy, 5: 417. DOI: 10.2147/OTT.S36366
    Back to article
  21. 21Cao, Y, Jin, Y, Yu, J, Wang, J, Yan, J and Zhao, Q. 2017. Research progress of neuroblastoma related gene variations. Oncotarget, 8(11): 18444. DOI: 10.18632/oncotarget.14408
    Back to article
  22. 22Caron, H, van Sluis, P, de Kraker, J, Bökkerink, J, Egeler, M, Laureys, G, Slater, R, Westerveld, A, Voute, P and Versteeg, R. 1996. Allelic loss of chromosome 1p as a predictor of unfavorable outcome in patients with neuroblastoma. New England Journal of Medicine, 334(4): 225–230. DOI: 10.1056/NEJM199601253340404
    Back to article
  23. 23Cheung, N-KV, Zhang, J, Lu, C, Parker, M, Bahrami, A, Tickoo, SK, Heguy, A, Pappo, AS, Federico, S, Dalton, J, Cheung, IY, Ding, L, Fulton, R, Wang, J, Chen, X, Becksfort, J, Wu, J, Billups, CA, Ellison, D, Mardis, ER, Wilson, RK, Downing, JR, Dyer, MA and St Jude Children’s Research Hospital Washington University Pediatric Cancer Genome Project. 2012. Association of age at diagnosis and genetic mutations in patients with neuroblastoma. Journal of the American Medical Association, 307(10): 1062–1071. DOI: 10.1001/jama.2012.228
    Back to article
  24. 24Chicco, D and Jurman, G. 2020. Survival prediction of patients with sepsis from age, sex, and septic episode number alone. Scientific Reports, 10(1): 1–12, 2020. DOI: 10.1038/s41598-020-73558-3
    Back to article
  25. 25Children with Cancer UK. 2021. Neuroblastoma overview. https://www.childrenwithcancer.org.uk/childhood-cancer-info/cancer-types/neuroblastoma/ URL visited on 11th November 2021.
    Back to article
  26. 26Choi, YB, Son, MH, Cho, HW, Ma, Y, Lee, JW, Kang, E-S, Yoo, KH, Her, JH, Lim, O, Jung, M, Hwang, YK, Sung, KW and Koo, HH. 2019. Safety and immune cell kinetics after donor natural killer cell infusion following haploidentical stem cell transplantation in children with recurrent neuroblastoma. PLOS One, 14(12): e0225998. DOI: 10.1371/journal.pone.0225998
    Back to article
  27. 27Clark, K, Vendt, B, Smith, K, Freymann, J, Kirby, J, Koppel, P, Moore, S, Phillips, S, Maffitt, D, Pringle, M, Tarbox, L and Prior, F. 2013. The Cancer Imaging Archive (TCIA): Maintaining and operating a public information repository. Journal of Digital Imaging, 26(6): 1045–1057. DOI: 10.1007/s10278-013-9622-7
    Back to article
  28. 28Cohn, SL, Pearson, AD, London, WB, Monclair, T, Ambros, PF, Brodeur, GM, Faldum, A, Hero, B, Iehara, T, Machin, D, Mosseri, V, Simon, T, Garaventa, A, Castel, V and Matthay, KK. 2009. The International Neuroblastoma Risk Group (INRG) classification system: An INRG task force report. Journal of Clinical Oncology, 27(2): 289. DOI: 10.1200/JCO.2008.16.6785
    Back to article
  29. 29Colon, NC and Chung, DH. 2011. Neuroblastoma. Advances in Pediatrics, 58(1): 297–311. DOI: 10.1016/j.yapd.2011.03.011
    Back to article
  30. 30Creative Commons. 2022. Attribution-noncommercial 4.0 international (cc by-nc 4.0). https://creativecommons.org/licenses/by-nc/4.0/ URL visited on 26th July 2022.
    Back to article
  31. 31Federico, SM, Allewelt, H, Spunt, SL, Hudson, MM, Wu, J, Billups, CA, Jenkins, J, Santana, VM, Furman, WL and McGregor, LM. 2015. Subsequent malignant neoplasms in pediatric patients initially diagnosed with neuroblastoma. Journal of Pediatric Hematology/Oncology, 37(1): e6. DOI: 10.1097/MPH.0000000000000148
    Back to article
  32. 32Ferraro, S, Braga, F, Luksch, R, Terenziani, M, Caruso, S and Panteghini, M. 2020. Measurement of serum neuron-specific enolase in neuroblastoma: Is there a clinical role? Clinical Chemistry, 66(5): 667–675. DOI: 10.1093/clinchem/hvaa073
    Back to article
  33. 33Francescatto, M, Chierici, M, Rezvan Dezfooli, S, Zandoná, A, Jurman, G and Furlanello, C. 2018. Multi-omics integration for neuroblastoma clinical endpoint prediction. Biology Direct, 13(1): 1–12. DOI: 10.1186/s13062-018-0207-8
    Back to article
  34. 34Georgantzi, K, Sköldenberg, EG, Stridsberg, M, Kogner, P, Jakobson, A, Janson, ET and Christofferson, RH. 2018. Chromogranin A and neuron-specific enolase in neuroblastoma: correlation to stage and prognostic factors. Pediatric Hematology and Oncology, 35(2): 156–165. DOI: 10.1080/08880018.2018.1464087
    Back to article
  35. 35Google. 2021. Google Scholar. https://scholar.google.com URL visited on 1st November 2011.
    Back to article
  36. 36Google. 2022. Google Dataset Search. https://datasetsearch.research.google.com/ URL visited on 4th April 2022.
    Back to article
  37. 37Haghiri, S, Fayech, C, Mansouri, I, Dufour, C, Pasqualini, C, Bolle, S, Rivollet, S, Dumas, A, Boumaraf, A, Belhout, A, Journy, N, Souchard, V, Vu-Bezin, G, Veres, C, Haddy, N, De Vathaire, F, Valteau-Couanet, D and Fresneau, B. 2021. Long-term follow-up of high-risk neuroblastoma survivors treated with high-dose chemotherapy and stem cell transplantation rescue. Bone Marrow Transplantation, 56: 1984–1997. DOI: 10.1038/s41409-021-01258-1
    Back to article
  38. 38Hann, H-WL, Evans, AE, Siegel, SE, Wong, KY, Sather, H, Dalton, A, Hammond, D and Seeger, RC. 1985. Prognostic importance of serum ferritin in patients with Stages III and IV neuroblastoma: The Children’s Cancer Study Group experience. Cancer Research, 45(6): 2843–2848.
    Back to article
  39. 39International Neuroblastoma Risk Group. 2017. INRG Data Commons. https://inrgdb.org/ URL visited on 2nd March 2022.
    Back to article
  40. 40Janoueix-Lerosey, I, Schleiermacher, G, Michels, E, Mosseri, V, Ribeiro, A, Lequin, D, Vermeulen, J, Couturier, J, Peuchmaur, M, Valent, A, Plantaz, D, Rubie, H, Valteau-Couanet, D, Thomas, C, Combaret, V, Rousseau, R, Eggert, A, Michon, J, Speleman, F and Delattre, O. 2009. Overall genomic pattern is a predictor of outcome in neuroblastoma. Journal of Clinical Oncology, 27(7): 1026–1033. DOI: 10.1200/JCO.2008.16.0630
    Back to article
  41. 41Kaggle. 2022. Kaggle.com – Find open datasets. https://www.kaggle.com/datasets URL visited on 27th March 2022.
    Back to article
  42. 42Keikhaei, B, Pedram, M, Popak, B, Heidari, M, Hadadi, N and Samadi, B. 2012. Signs and symptoms of neuroblastoma. Journal of Medicine and Medical Science, 3(4): 243–246.
    Back to article
  43. 43Kent, DM, Steyerberg, E and van Klaveren, D. 2018. Personalized evidence based medicine: predictive approaches to heterogeneous treatment effects. BMJ, 363. DOI: 10.1136/bmj.k4245
    Back to article
  44. 44Khan, SM, Liu, X, Nath, S, Korot, E, Faes, L, Wagner, SK, Keane, PA, Sebire, NJ, Burton, MJ and Denniston, AK. 2021. A global review of publicly available datasets for ophthalmological imaging: barriers to access, usability, and generalisability. The Lancet Digital Health, 3(1): e51–e66. DOI: 10.1016/S2589-7500(20)30240-5
    Back to article
  45. 45Kim, C, Choi, YB, Lee, JW, Yoo, KH, Sung, KW and Koo, HH. 2018. Excellent treatment outcomes in children younger than 18 months with stage 4 MYCN nonamplified neuroblastoma. Korean Journal of Pediatrics, 61(2): 53. DOI: 10.3345/kjp.2018.61.2.53
    Back to article
  46. 46Kueffner, R, Zach, N, Bronfeld, M, Norel, R, Atassi, N, Balagurusamy, V, Di Camillo, B, Chio, A, Cudkowicz, M, Dillenberger, D, Garcia-Garcia, J, Hardiman, O, Hoff, B, Knight, J, Leitner, ML, Li, G, Mangravite, L, Norman, T, Wang, L, the ALS Stratification Consortium, Xiao, J, Fang, W-C, Peng, J, Yang, C, Chang, H-J and Stolovitzky, G. 2019. Stratification of amyotrophic lateral sclerosis patients: A crowdsourcing approach. Scientific Reports, 9(1): 690. DOI: 10.1038/s41598-018-36873-4
    Back to article
  47. 47Lastowska, M, Cotterill, S, Pearson, A, Roberts, P, McGuckin, A, Lewis, I and Bown, N. 1997. Gain of chromosome arm 17q predicts unfavourable outcome in neuroblastoma patients. UK Children’s Cancer Study Group and the UK Cancer Cytogenetics Group. European Journal of Cancer, 33(10): 1627–1633. DOI: 10.1016/S0959-8049(97)00282-7
    Back to article
  48. 48Ma, Y, Zheng, J, Feng, J, Chen, L, Dong, K and Xiao, X. 2018. Neuroblastomas in Eastern China: A retrospective series study of 275 cases in a regional center. PeerJ, 6: e5665. DOI: 10.7717/peerj.5665
    Back to article
  49. 49Maris, JM. 2010. Recent advances in neuroblastoma. New England Journal of Medicine, 362(23): 2202–2211. DOI: 10.1056/NEJMra0804577
    Back to article
  50. 50Matsumura, T, Terada, J, Kinoshita, T, Sakurai, Y, Yahaba, M, Tsushima, K, Sakao, S, Nagashima, K, Ozaki, T, Kobayashi, Y, Hiwasa, T and Tatsumi, K. 2018. Circulating autoantibodies against neuroblastoma suppressor of tumorigenicity 1 (NBL1): A potential biomarker for coronary artery disease in patients with obstructive sleep apnea. PLOS One, 13(3): e0195015. DOI: 10.1371/journal.pone.0195015
    Back to article
  51. 51Melaiu, O, Chierici, M, Lucarini, V, Jurman, G, Conti, LA, De Vito, R, Boldrini, R, Cifaldi, L, Castellano, A, Furlanello, C, Barnaba, V, Locatelli, F and Fruci, D. 2020. Cellular and gene signatures of tumor-infiltrating dendritic cells and natural-killer cells predict prognosis of neuroblastoma. Nature Communications, 11(1): 1–15. DOI: 10.1038/s41467-020-19781-y
    Back to article
  52. 52Moroz, V, Machin, D, Hero, B, Ladenstein, R, Berthold, F, Kao, P, Obeng, Y, Pearson, AD, Cohn, SL and London, WB. 2020. The prognostic strength of serum LDH and serum ferritin in children with neuroblastoma: A report from the International Neuroblastoma Risk Group (INRG) project. Pediatric Blood & Cancer, 67(8): e28359. DOI: 10.1002/pbc.28359
    Back to article
  53. 53National Health Institutes (NIH), Genetic and Rare Diseases Information Center (GARD). 2021. Chromosome 11q deletion. https://rarediseases.info.nih.gov/diseases/1735/chromosome-11q-deletion URL visited on 5th November 2021.
    Back to article
  54. 54Noguera, R 7th November 2021 Personal communication (email).
    Back to article
  55. 55Ognibene, M, Cangelosi, D, Morini, M, Segalerba, D, Bosco, MC, Sementa, AR, Eva, A and Varesio, L. 2017. Immunohistochemical analysis of PDK1, PHD3 and HIF-1á expression defines the hypoxic status of neuroblastoma tumors. PLOS One, 12(11): e0187206. DOI: 10.1371/journal.pone.0187206
    Back to article
  56. 56O’Neill, S, Ekstrom, L, Lastowska, M, Roberts, P, Brodeur, GM, Kees, UR, Schwab, M and Bown, N. 2001. MYCN amplification and 17q in neuroblastoma: evidence for structural association. Genes, Chromosomes and Cancer, 30(1): 87–90. DOI: 10.1002/1098-2264(2000)9999:9999<;::AID-GCC1055>3.0.CO;2-J
    Back to article
  57. 57Park, JR, Bagatell, R, Cohn, SL, Pearson, AD, Villablanca, JG, Berthold, F, Burchill, S, Boubaker, A, McHugh, K, Nuchtern, JG, London, WB, Seibel, NL, Lindwasser, OW, Maris, JM, Brock, P, Schleiermacher, G, Ladenstein, R, Matthay, KK and Valteau-Couanet, D. 2017. Revisions to the international neuroblastoma response criteria: a consensus statement from the national cancer institute clinical trials planning meeting. Journal of Clinical Oncology, 35(22): 2580. DOI: 10.1200/JCO.2016.72.0177
    Back to article
  58. 58Pautasso, M. 2013. Ten simple rules for writing a literature review. PLOS Computational Biology, 9(7): e1003149. DOI: 10.1371/journal.pcbi.1003149
    Back to article
  59. 59Pelizzari, G, Basile, D, Zago, S, Lisanti, C, Bartoletti, M, Bortot, L, Vitale, MG, Fanotto, V, Barban, S, Cinausero, M, Bonotto, M, Gerratana, L, Mansutti, M, Curcio, F, Fasola, G, Minisini, AM and Puglisi, F. 2019. Lactate dehydrogenase (LDH) response to first-line treatment predicts survival in metastatic breast cancer: First clues for a cost-effective and dynamic biomarker. Cancers, 11(9): 1243. DOI: 10.3390/cancers11091243
    Back to article
  60. 60Plana, A, Furner, B, Palese, M, Dussault, N, Birz, S, Graglia, L, Kush, M, Nicholson, J, Hecker-Nolting, S, Gaspar, N, Rasche, M, Bisogno, G, Reinhardt, D, Zwaan, CM, Koscielniak, E, Frazier, AL, Janeway, K, Hawkins, DS, Kolb, EA, Cohn, SL, Pearson, ADJ and Volchenboum, SL. 2021. Volchenboum. Pediatric cancer data commons: federating and democratizing data for childhood cancer research. JCO Clinical Cancer Informatics, 5: 1034–1043. DOI: 10.1200/CCI.21.00075
    Back to article
  61. 61Qi, Y and Zhan, J. 2021. Roles of surgery in the treatment of patients with high-risk neuroblastoma in the children oncology group study: A systematic review and meta-analysis. Frontiers in Pediatrics, 9: 1–9. DOI: 10.3389/fped.2021.706800
    Back to article
  62. 62Quinn, JJ, Altman, AJ and Frantz, CN. 1980. Serum lactic dehydrogenase, an indicator of tumor activity in neuroblastoma. Journal of Pediatrics, 97(1): 89–91. DOI: 10.1016/S0022-3476(80)80139-9
    Back to article
  63. 63Re3data. 2022. Registry of research data repositories. https://www.re3data.org/ URL visited on 24th June 2022.
    Back to article
  64. 64Romani, M. 8th November 2021. Personal communication (email).
    Back to article
  65. 65Rosenbaum, DG, Abramson, SJ, DeLappe, E, Teruya-Feldstein, J, La Quaglia, MP, Fox, JJ and Price, AP. 2013. Pancreatic involvement in neuroblastoma with radiologic-pathologic correlation: A single-institution experience. American Journal of Roentgenology, 201(1): W141–W146. DOI: 10.2214/AJR.12.9618
    Back to article
  66. 66Shimada, H, Umehara, S, Monobe, Y, Hachitanda, Y, Nakagawa, A, Goto, S, Gerbing, RB, Stram, DO, Lukens, JN and Matthay, KK. 2001. International neuroblastoma pathology classification for prognostic evaluation of patients with peripheral neuroblastic tumors: A report from the children’s cancer group. Cancer, 92(9): 2451–2461. DOI: 10.1002/1097-0142(20011101)92:9<;2451::AID-CNCR1595>3.0.CO;2-S
    Back to article
  67. 67Smith, SJ, Diehl, NN, Smith, BD and Mohney, BG. 2010. Urine catecholamine levels as diagnostic markers for neuroblastoma in a defined population: Implications for ophthalmic practice. Eye, 24(12): 1792–1796. DOI: 10.1038/eye.2010.125
    Back to article
  68. 68Software Carpentry. 2022. Reading and writing CSV files. https://swcarpentry.github.io/r-novice-inflammation/11-supp-read-write-csv/ URL visited on 27th March 2022.
    Back to article
  69. 69Sokol, E and Desai, AV. 2019. The evolution of risk classification for neuroblastoma. Children, 6(2): 27. DOI: 10.3390/children6020027
    Back to article
  70. 70Spix, C, Pastore, G, Sankila, R, Stiller, CA and Steliarova-Foucher, E. 2006. Neuroblastoma incidence and survival in European children (1978–1997): Report from the Automated Childhood Cancer Information System project. European Journal of Cancer, 42(13): 2081–2091. DOI: 10.1016/j.ejca.2006.05.008
    Back to article
  71. 71Stall, S, Yarmey, L, Cutcher-Gershenfeld, J, Hanson, B, Lehnert, K, Nosek, B, Parsons, M, Robinson, E and Wyborn, L. 2019. Make scientific data FAIR. Nature, 570(7759): 27–29. DOI: 10.1038/d41586-019-01720-7
    Back to article
  72. 72Strenger, V, Kerbl, R, Dornbusch, HJ, Ladenstein, R, Ambros, PF, Ambros, IM and Urban, C. 2007. Diagnostic and prognostic impact of urinary catecholamines in neuroblastoma patients. Pediatric Blood & Cancer, 48(5): 504–509. DOI: 10.1002/pbc.20888
    Back to article
  73. 73The Document Foundation. 2022. LibreOffice Calc. https://www.libreoffice.org/discover/calc/ URL visited on 18th January 2022.
    Back to article
  74. 74Tolbert, VP and Matthay, KK. 2018. Neuroblastoma: Clinical and biological approach to risk stratification and treatment. Cell and Tissue Research, 372(2): 195–209. DOI: 10.1007/s00441-018-2821-2
    Back to article
  75. 75Trahair, TN, Vowels, MR, Johnston, K, Cohn, RJ, Russell, S, Neville, KA, Carroll, S and Marshall, GM. 2007. Long-term outcomes in children with high-risk neuroblastoma treated with autologous stem cell transplantation. Bone Marrow Transplantation, 40(8): 741–746. DOI: 10.1038/sj.bmt.1705809
    Back to article
  76. 76University of California Irvine. 1987. Machine Learning Repository. https://archive.ics.uci.edu/ml URL visited on 8th November 2021.
    Back to article
  77. 77US National Center for Biotechnology Information. 2021. Gene Expression Omnibus. https://www.ncbi.nlm.nih.gov/geo URL visited on 8th November 2021.
    Back to article
  78. 78Villamón, E, Berbegall, AP, Piqueras, M, Tadeo, I, Castel, V, Djos, A, Martinsson, T, Navarro, S and Noguera, R. 2013. Genetic instability and intratumoral heterogeneity in neuroblastoma with MYCN amplification plus 11q deletion. PLOS One, 8(1): e53740. DOI: 10.1371/journal.pone.0053740
    Back to article
  79. 79Volchenboum, S, Cohen, E, Furner, B and the Pediatric Cancer Data Commons Team. 2021. Pediatric Cancer Data Commons. https://commons.cri.uchicago.edu/ URL visited on 27th March 2022.
    Back to article
  80. 80Volchenboum, SL, Cox, SM, Heath, A, Resnick, A, Cohn, SL and Grossman, R. 2017. Data commons to support pediatric cancer research. American Society of Clinical Oncology Educational Book, 37: 746–752, 2017. DOI: 10.1200/EDBK_175029
    Back to article
  81. 81Wickham, H. 2016. Programming with ggplot2. In ggplot2, pages 241–253. Springer. DOI: 10.1007/978-3-319-24277-4_12
    Back to article
  82. 82Wilkinson, M, Dumontier, M, Aalbersberg, I, Appleton, G, Axton, M, Baak, A, Blomberg, N, Boiten, J, da Silva Santos, L, Bourne, P, Bouwman, J, Brookes, A, Clark, T, Crosas, M, Dillo, I, Dumon, O, Edmunds, S, Evelo, C, Finkers, R, Gonzalez-Beltran, A, Gray, A, Groth, P, Goble, C, Grethe, J, Heringa, J, ‘t Hoen, P, Hooft, R, Kuhn, T, Kok, R, Kok, J, Lusher, S, Martone, M, Mons, A, Packer, A, Persson, B, Rocca-Serra, P, Roos, M, van Schaik, R, Sansone, S, Schultes, E, Sengstag, T, Slater, T, Strawn, G, Swertz, M, Thompson, M, Van Der Lei, J, Van Mulligen, E, Velterop, J, Waagmeester, A, Wittenburg, P, Wolstencroft, K, Zhao, J and Mons, B. 2016. The FAIR guiding principles for scientific data management and stewardship. Scientific Data, 3: 160018. DOI: 10.1038/sdata.2016.18
    Back to article
  83. 83Williams, LA, Richardson, M, Marcotte, EL, Poynter, JN and Spector, LG. 2019. Sex ratio among childhood cancers by single year of age. Pediatric Blood & Cancer, 66(6): e27620. DOI: 10.1002/pbc.27620
    Back to article
  84. 84Yin, C, Jiang, C, Liao, F, Rong, Y, Cai, X, Guo, G, Qiu, H, Chen, X, Zhang, B, He, W and Xia, L. 2014. Initial LDH level can predict the survival benefit from bevacizumab in the first-line setting in Chinese patients with metastatic colorectal cancer. OncoTargets and Therapy, 7: 1415. DOI: 10.2147/OTT.S64559
    Back to article
DOI: https://doi.org/10.5334/dsj-2022-017 | Journal eISSN: 1683-1470
Journal RSS Feed
Language: English
Submitted on: May 3, 2022
Accepted on: Aug 19, 2022
Published on: Oct 4, 2022
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
neuroblastoma,
electronic health records,
EHR,
datasets,
data,
open data,
neuro-oncology,
childhood cancer,
pediatric oncology

© 2022 Davide Chicco, Gabriel Cerono, Davide Cangelosi, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.

Previous articleVolume 21 (2022): Issue 1Next article